SHANGHAI, Aug 4 (Reuters) - A Chinese group led by drugmaker Shanghai Pharmaceuticals Holding Co Ltd <601607.SS> and private equity firm Primavera Capital has agreed to buy Australian vitamins maker Vitaco Holdings (VIT) for A$313.7 million ($239 million).
Vitaco said in a statement on Thursday the Chinese group would buy all of the firm at a valuation of A$2.25 per share, a 28 percent premium to their closing price on Wednesday, less than a year after it listed shares in Sydney at A$2.10 apiece.
Vitaco said the deal would help it grow in the world's second-largest economy, where vitamins and dietary supplements business is expected to surge to around $20 billion by 2018, according to Euromonitor. That growth is luring firms to look for local tie-ups or tap the market for traditional remedies.
Shares in Vitaco, which owns brands such as Nutra-Life, Wagner and Abundant Earth, has seen the stock plunge over 40 percent from a high of A$3.23 last November, in the month after it listed.
Vitaco's chairman Greg Richards said in a statement the deal was attractive for shareholders given the "ongoing volatile macroeconomic conditions and regulatory uncertainty in China". While China is a major destination for Australian goods, Beijing's move last April to raise tariffs and tighten controls on some imports clouded the business outlook for some players.
Shanghai Pharma said in a filing on Thursday it would take a 60 percent stake of Vitaco for around 938 million yuan ($141 million) as part of a take-private deal with Primavera. It said the deal would combine its own networks and sales channels in China with Vitaco's high-quality healthcare brands.
The Vitaco buyout comes less than a year after Hong Kong-listed Biostime International Holdings <1112.HK> bought larger Australian vitamin maker Swisse Wellness for around $1 billion in 2015 to build on strong Chinese demand. ($1 = 6.6320 Chinese yuan renminbi) ($1 = 1.3142 Australian dollars)
- Forums
- ASX - By Stock
- VIT
- News: Chinese group to buy Australian vitamin firm Vitaco for $239 mln
News: Chinese group to buy Australian vitamin firm Vitaco for $239 mln
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $55.28M |
Open | High | Low | Value | Volume |
9.6¢ | 9.8¢ | 9.6¢ | $24.52K | 255.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5400 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.8¢ | 74824 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5400 | 0.095 |
3 | 86984 | 0.094 |
1 | 10763 | 0.093 |
1 | 49401 | 0.091 |
2 | 280233 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.098 | 74824 | 4 |
0.099 | 90000 | 1 |
0.100 | 75659 | 3 |
0.105 | 127728 | 3 |
0.110 | 75167 | 5 |
Last trade - 15.56pm 20/06/2024 (20 minute delay) ? |
Featured News
VIT (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Chairman
Nick Poll
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online